Indglobl Nextgen Medicare Limited
About Indglobl Nextgen Medicare Limited
Data last updated:
Indglobl Nextgen Medicare Limited is a public limited company based in Chengalpattu, Tamil Nadu, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 13 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2015PLC100070. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Raghavachari Anandapadmanaban and Mary Rini George.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 44 – 785 Illalur Main Road Thirupporur, Chengalpattu, Tamil Nadu, India – 603110.
As per the financials filed for FY 2019, the company reported a revenue of ₹88.5 Lakh, a growth of 53% compared to the previous year. For the same year it recorded a net profit of ₹42,509 (net margin 0.5%) and EBITDA of ₹1.29 Lakh (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 79% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Indglobl Nextgen Medicare Limited's registered office is in Chengalpattu, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address44 – 785 Illalur Main Road Thirupporur, Chengalpattu, Tamil Nadu, India – 603110
- IndustryLife Sciences, Biotechnology
To see the full contact details of Indglobl Nextgen Medicare Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indglobl Nextgen Medicare is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Indglobl Nextgen Medicare Limited, buy the company report.
Financials of Indglobl Nextgen Medicare Limited
FY 2020 filings availableIndglobl Nextgen Medicare Limited reported revenue of ₹88.5 Lakh (up 53% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 79% over three years, including 53% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹88.5 Lakh | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.29 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹42,509 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.5% | |||
| Net Profit Margin | 0.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Indglobl Nextgen Medicare Limited, buy the company report.
Board of directors of Indglobl Nextgen Medicare Limited
Indglobl Nextgen Medicare has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raghavachari Anandapadmanaban | Director | 13 Apr 2015 | 11 Years 6 Months | Current |
| Mary Rini George | Director | 13 Apr 2015 | 11 Years 6 Months | Current |
| Perumal Vijayakumar | Director | 15 Dec 2021 | 4 Years 10 Months | Current |
Auditor
Indglobl Nextgen Medicare Limited is audited by PKR & Company for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PKR & Company | FY 2019 | 207658 |
Shareholding
The shareholding of Indglobl Nextgen Medicare Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Indglobl Nextgen Medicare Limited, buy the company report.
Legal cases
No court or tribunal cases involving Indglobl Nextgen Medicare Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indglobl Nextgen Medicare Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indglobl Nextgen Medicare has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Indglobl Nextgen Medicare Limited, buy the company report.
Recent activity
Indglobl Nextgen Medicare Limited has 13 board changes on record since 2015: 8 appointments and 5 cessations. The latest: Jayachandran Sankaran ceased to be Director on 10 Jan 2022.
4 earlier events are in the company report.
Frequently asked questions
Indglobl Nextgen Medicare is an active public limited company based in Chengalpattu, Tamil Nadu, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 13 April 2015 (11+ years old) and is registered under CIN U74900TN2015PLC100070.
Indglobl Nextgen Medicare has 3 current directors:
- Raghavachari Anandapadmanaban - Director
- Mary Rini George - Director
- Perumal Vijayakumar - Director
The latest financial statements of Indglobl Nextgen Medicare on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2016 are in the company report.
No. Indglobl Nextgen Medicare has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Indglobl Nextgen Medicare is U74900TN2015PLC100070. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indglobl Nextgen Medicare was incorporated on 13 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
Jayachandran Sankaran ceased to be Director on 10 Jan 2022. Perumal Vijayakumar was appointed as Director on 15 Dec 2021. Jayachandran Sankaran was appointed as Director on 05 Apr 2018. Indglobl Nextgen Medicare has 13 board changes on record in total.
The registered office of Indglobl Nextgen Medicare is at 44 – 785 Illalur Main Road Thirupporur, Chengalpattu, Tamil Nadu, India – 603110.
Indglobl Nextgen Medicare operates in the life sciences industry, in the biotechnology segment.
The compliance status of Indglobl Nextgen Medicare is compliant as of 20 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
